Original researchClinical Implications of Assisted Peak Cough Flow Measured With an External Glottic Control Device for Tracheostomy Decannulation in Patients With Neuromuscular Diseases and Cervical Spinal Cord Injuries: A Pilot Study
Section snippets
Patients
This study included patients with neuromuscular diseases and cervical spinal cord injuries who were tracheostomized and did not satisfy the criterion for decannulation of an APCF of 160L/min, the minimum value necessary for adequate clearance of secretions. They were admitted to the Department of Rehabilitation Medicine at Gangnam Severance Hospital from February 1, 2009 to September 30, 2014. Among patients whose APCF with the tracheostomy tube in place was too low to be measured or <160L/min,
Characteristics and ventilatory status of the patients
During the research period, there were 62 candidates with neuromuscular diseases and cervical spinal cord injuries who met the requirements of decannulation, except APCF. In 26 patients (41.9%), APCF was ≥160L/min without assistance of the device. And in 20 patients (32.3%), APCF could not reach 160L/min even with the use of this device. Therefore, the other 16 patients (25.8%) met the inclusion criteria for this study and were analyzed. The mean age of patients was 43.9 years (range, 19–76y),
Discussion
The process of cough consists of inspiratory, compressive, and expiratory phases.20, 21 The air that is deeply inhaled in the inspiratory phase is trapped in the airway by the closing of the glottis in the compressive phase. With the action of expiratory muscles, intra-thoracic pressure is increased, and by the sudden opening of the glottis, a cough is induced. If any of the 3 phases is impaired, a cough cannot be induced effectively. Inspiratory and expiratory phases of cough can be supported
Conclusions
This study indicates that an external control device substituting for glottic function is beneficial for determining tracheostomy decannulation because it provides an objective and accurate measurement of APCF. Therefore, this device is helpful, particularly in patients whose APCF is ≥160L/min while using the device, even if APCF is <160L/min without this device.
Supplier
- a.
Philips Respironics.
References (22)
A comparison of long-term ventilatory support alternatives from the perspective of the patient and care giver
Chest
(1993)- et al.
Special critical care considerations in tracheostomy management
Clin Chest Med
(1991) - et al.
Criteria for extubation and tracheostomy tube removal for patients with ventilatory failure: a different approach to weaning
Chest
(1996) - et al.
External control of exhalation for cough assistance: a method for patients with glottis dysfunction and/or tracheostomy
Arch Phys Med Rehabil
(2009) - et al.
Prevention of pulmonary morbidity for patients with Duchenne muscular dystrophy
Chest
(1997) - et al.
Pathophysiology of cough
Clin Chest Med
(1987) - et al.
Outcome of mechanically ventilated patients who require a tracheostomy
Crit Care Med
(2005) - et al.
How is mechanical ventilation employed in the intensive care unit? An international utilization review
Am J Respir Crit Care Med
(2000) - et al.
Noninvasive ventilation after intubation and mechanical ventilation
Eur Respir J
(2002) - et al.
Tracheostomy: complications and their management
Arch Otolaryngol
(1972)
Ventilator weaning by lung expansion and decannulation
Am J Phys Med Rehabil
Cited by (0)
Supported by a faculty research grant from the Yonsei University College of Medicine for 2014 (grant no. 6-2014-0015).
Disclosures: S.-W.K. holds a patent for a device for assisting cough and lung expansion in patients with paralytic bulbar musculature (patent no. 100516324). The other authors have nothing to disclose.